Susan J. Clark
#138,090
Most Influential Person Now
Australian biomedical researcher
Susan J. Clark's AcademicInfluence.com Rankings
Susan J. Clarklaw Degrees
Law
#2884
World Rank
#3597
Historical Rank
Common Law
#166
World Rank
#179
Historical Rank
Susan J. Clarkbiology Degrees
Biology
#10673
World Rank
#14024
Historical Rank
Molecular Biology
#2371
World Rank
#2408
Historical Rank
Download Badge
Law Biology
Susan J. Clark's Degrees
- PhD Biomedical Science Monash University
Why Is Susan J. Clark Influential?
(Suggest an Edit or Addition)According to Wikipedia, Professor Susan J. Clark is an Australian biomedical researcher in epigenetics of development and cancer. She was elected a Fellow of the Australian Academy of Science in 2015, and is a National Health and Medical Research Council Senior Principal Research Fellow and Research Director and Head of Genomics and Epigenetics Division at the Garvan Institute of Medical Research. Clark developed the first method for bisulphite sequencing for DNA methylation analysis and used it to establish that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites and showed is inheritable. Clark's research has advanced understanding of the role of DNA methylation, non-coding RNA and microRNA in embryogenesis, reprogramming, stem cell development and cancer and has led to the identification of epigenomic biomarkers in cancer. Clark is a founding member of the International Human Epigenome Consortium and President of the Australian Epigenetics Alliance .
Susan J. Clark's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- High sensitivity mapping of methylated cytosines. (1994) (1953)
- miRNA‐dependent gene silencing involving Ago2‐mediated cleavage of a circular antisense RNA (2011) (802)
- Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling (2016) (746)
- Bisulfite genomic sequencing: systematic investigation of critical experimental parameters (2001) (712)
- De novo identification of differentially methylated regions in the human genome (2015) (600)
- Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band (2006) (397)
- Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. (1997) (386)
- Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. (1999) (341)
- Identification and resolution of artifacts in bisulfite sequencing. (2002) (302)
- Methyl-CpG-binding domain proteins: readers of the epigenome. (2015) (300)
- DNA methylation and gene silencing in cancer: which is the guilty party? (2002) (296)
- Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. (1997) (293)
- Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer (2011) (280)
- DNA Methylation: Bisulphite Modification and Analysis (2011) (279)
- CpNpG methylation in mammalian cells (1995) (275)
- Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations (2016) (253)
- Quantitative comparison of DNA methylation assays for biomarker development and clinical applications (2016) (251)
- Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancer (1999) (245)
- Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements (2007) (236)
- Transcriptional Gene Silencing Promotes DNA Hypermethylation through a Sequential Change in Chromatin Modifications in Cancer Cells (2004) (236)
- Epigenetics in prostate cancer: biologic and clinical relevance. (2011) (221)
- Moving AHEAD with an international human epigenome project (2008) (202)
- Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias (2011) (191)
- Sp1 binding is inhibited by mCpmCpG methylation (1997) (190)
- DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. (2008) (189)
- Regional activation of the cancer genome by long-range epigenetic remodeling. (2013) (185)
- Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity (2010) (184)
- Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer (2014) (180)
- Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer. (2012) (178)
- Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells (2002) (178)
- Bisulfite sequencing of chromatin immunoprecipitated DNA (BisChIP-seq) directly informs methylation status of histone-modified DNA (2012) (173)
- Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. (1998) (163)
- Mining cancer methylomes: prospects and challenges. (2014) (163)
- Hypermethylation of E-cadherin in leukemia. (2000) (160)
- MicroRNA Alterations and Associated Aberrant DNA Methylation Patterns across Multiple Sample Types in Oral Squamous Cell Carcinoma (2011) (149)
- DNA methylation: Bisulphite modification and analysis (2006) (149)
- Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value (2015) (143)
- Sp1 binding is inhibited by (m)Cp(m)CpG methylation. (1997) (131)
- Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. (2007) (126)
- Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer (2014) (120)
- Low O6‐methylguanine‐DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours (2009) (119)
- Loss of annexin II heavy and light chains in prostate cancer and its precursors. (2001) (118)
- Evaluation of affinity-based genome-wide DNA methylation data: effects of CpG density, amplification bias, and copy number variation. (2010) (117)
- Bisulfite sequencing in preimplantation embryos: DNA methylation profile of the upstream region of the mouse imprinted H19 gene. (1998) (111)
- Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer. (2012) (103)
- Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer (2010) (101)
- DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer (2015) (99)
- Epigenetic and phenotypic changes result from a continuous pre and post natal dietary exposure to phytoestrogens in an experimental population of mice (2008) (98)
- Conversion-specific detection of DNA methylation using real-time polymerase chain reaction (ConLight-MSP) to avoid false positives. (2002) (95)
- Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer (2013) (94)
- Breast cancer epigenetics: normal human mammary epithelial cells as a model system (2008) (94)
- Impact of the Genome on the Epigenome Is Manifested in DNA Methylation Patterns of Imprinted Regions in Monozygotic and Dizygotic Twins (2011) (90)
- Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis. (2007) (90)
- DNA Methylation Profile of the Mouse Skeletal α-Actin Promoter during Development and Differentiation (1999) (89)
- A Distinct Sequence (ATAAA) n Separates Methylated and Unmethylated Domains at the 5′-End of theGSTP1 CpG Island*210 (2000) (84)
- ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer (2012) (82)
- Transient and Permanent Reconfiguration of Chromatin and Transcription Factor Occupancy Drive Reprogramming. (2017) (81)
- Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription (2011) (80)
- Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer (2012) (76)
- Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. (2009) (75)
- Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer. (2007) (73)
- Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer (2020) (72)
- Cytosine methylation: quantitation by automated genomic sequencing and GENESCAN analysis. (1996) (71)
- Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer (2014) (70)
- Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease (2009) (68)
- Permissive Transcriptional Activity at the Centromere through Pockets of DNA Hypomethylation (2005) (68)
- Enduring epigenetic landmarks define the cancer microenvironment (2018) (67)
- Repitools: an R package for the analysis of enrichment-based epigenomic data (2010) (66)
- DNA methylation changes in leukaemia. (2002) (66)
- Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA (2017) (64)
- Methylation sequencing from limiting DNA: embryonic, fixed, and microdissected cells. (2002) (63)
- Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events (2012) (61)
- Alterations in the p16INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts (2004) (60)
- Multiple links between 5-methylcytosine content of mRNA and translation (2020) (60)
- Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer (2019) (59)
- Visualization of Biomedical Data (2018) (59)
- A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer. (2013) (58)
- Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer (2017) (58)
- Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains (2020) (56)
- Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma (2014) (55)
- Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer (2016) (55)
- Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer (2016) (55)
- ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells (2015) (54)
- Prostate cancer epigenetic biomarkers: next-generation technologies (2014) (52)
- DNA Hypermethylation Encroachment at CpG Island Borders in Cancer Is Predisposed by H3K4 Monomethylation Patterns. (2019) (52)
- Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers. (2012) (51)
- Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy (2005) (50)
- Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers (2010) (50)
- BCL-2 Hypermethylation Is a Potential Biomarker of Sensitivity to Antimitotic Chemotherapy in Endocrine-Resistant Breast Cancer (2013) (49)
- Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers or cancer cell lines. (2000) (49)
- Headloop suppression PCR and its application to selective amplification of methylated DNA sequences (2005) (48)
- Cytosines adjacent to methylated CpG sites can be partially resistant to conversion in genomic bisulfite sequencing leading to methylation artifacts. (1998) (47)
- Mutation and methylation analysis of TP53 in adrenal carcinogenesis. (2005) (45)
- MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene (2015) (44)
- Lineage Specific Methylation of the Elf5 Promoter in Mammary Epithelial Cells (2011) (43)
- Protocol matters: which methylome are you actually studying? (2010) (43)
- Genes and genomes: Sequencing 5‐methylcytosine residues in genomic DNA (1994) (42)
- Epigenetic architecture and miRNA: reciprocal regulators. (2010) (42)
- Collagen and calcium-binding EGF domains 1 is frequently inactivated in ovarian cancer by aberrant promoter hypermethylation and modulates cell migration and survival (2009) (41)
- Sequence-specific methylation of the mouse H19 gene in embryonic cells deficient in the Dnmt-1 gene. (1998) (38)
- ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer (2014) (37)
- Chromatin remodeler mutations in human cancers: epigenetic implications. (2014) (37)
- De novo identification of differentially methylated regions in the human genome (2015) (34)
- Disruption of the 3D cancer genome blueprint. (2017) (33)
- DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients (2016) (32)
- Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis (2012) (32)
- Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression (2019) (32)
- Macrophage development and activation involve coordinated intron retention in key inflammatory regulators (2020) (31)
- Direct cloning of polymerase chain reaction products in an XcmI T-vector. (1994) (31)
- Mother–child transmission of epigenetic information by tunable polymorphic imprinting (2018) (30)
- Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten (2018) (30)
- BayMeth: improved DNA methylation quantification for affinity capture sequencing data using a flexible Bayesian approach (2013) (30)
- Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial. (2019) (28)
- Alterations in Three-Dimensional Organization of the Cancer Genome and Epigenome. (2016) (25)
- Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis (2015) (25)
- Copy-number-aware differential analysis of quantitative DNA sequencing data (2012) (25)
- Multiplex bisulfite PCR resequencing of clinical FFPE DNA (2015) (24)
- MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer (2018) (24)
- NGSANE: a lightweight production informatics framework for high-throughput data analysis (2014) (22)
- Epigenomics of mammary gland development (2018) (22)
- Genome-wide DNA methylation profiling in triple-negative breast cancer reveals epigenetic signatures with important clinical value (2016) (20)
- DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrity. (2021) (20)
- Sequencing 5-methylcytosine residues in genomic DNA. (1994) (19)
- Mapping genomic and epigenomic evolution in cancer ecosystems (2021) (18)
- Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups (2019) (18)
- Methylome and transcriptome maps of human visceral and subcutaneous adipocytes reveal key epigenetic differences at developmental genes (2019) (18)
- Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells. (2006) (15)
- ELF5 modulates the estrogen receptor cistrome in breast cancer (2020) (14)
- Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer (2020) (14)
- Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels (2020) (14)
- The H2A.Z-nuclesome code in mammals: emerging functions. (2021) (14)
- Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways (2014) (13)
- Calling differentially methylated regions from whole genome bisulphite sequencing with DMRcate (2021) (13)
- Epigenetic markers of ovarian cancer. (2008) (13)
- Smoke-Induced Changes to the Epigenome Provide Fertile Ground for Oncogenic Mutation. (2017) (13)
- Advances in Prognostic Methylation Biomarkers for Prostate Cancer (2020) (13)
- Genome-wide nucleosome occupancy and DNA methylation profiling of four human cell lines (2014) (11)
- Transient exposure to miR‐203 enhances the differentiation capacity of established pluripotent stem cells (2020) (11)
- A Read/Write Mechanism Connects p300 Bromodomain Function to H2A.Z Acetylation (2019) (11)
- Nucleotide-Level Profiling of m⁵C RNA Methylation. (2016) (10)
- Benchmark study comparing liftover tools for genome conversion of epigenome sequencing data (2020) (10)
- DNA methylation analysis in mammalian cells. (2002) (10)
- Widespread Aberrant Alternative Splicing despite Molecular Remission in Chronic Myeloid Leukaemia Patients (2020) (9)
- BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer (2021) (9)
- COBRA-Seq: Sensitive and Quantitative Methylome Profiling (2015) (9)
- Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer. (2013) (8)
- Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas (2015) (8)
- Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements (2018) (8)
- Methylated glutathione s-transferase 1 (mGSTP1) as a potential plasma epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer (CRPC). (2014) (8)
- Bisulphite Differential Denaturation PCR for Analysis of DNA Methylation (2006) (8)
- GWAS of DNA Methylation Variation Within Imprinting Control Regions Suggests Parent-of-Origin Association (2013) (8)
- Dynamics of bivalent chromatin domains upon drug induced reactivation and resilencing in cancer cells (2011) (7)
- Epigenetic Therapies and Biomarkers in Breast Cancer (2022) (7)
- H2A.Z acetylation and transcription: ready, steady, go! (2016) (7)
- Epigenetic therapy suppresses endocrine-resistant breast tumour growth by re-wiring ER-mediated 3D chromatin interactions (2021) (6)
- Bisulphite Sequencing of Chromatin Immunoprecipitated DNA (BisChIP-seq). (2018) (6)
- Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer (2021) (5)
- Bisulfite methylation analysis of tumor suppressor genes in prostate cancer from fresh and archival tissue samples. (2003) (5)
- Studying Mammalian DNA Methylation: Bisulfite Modification (2004) (4)
- Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality (2022) (3)
- Annual Review of Biomedical Data Science Visualization of Biomedical Data (2019) (3)
- Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups (2019) (3)
- A study of methylated glutathione s-transferase 1 (mGSTP1)as a potential plasma epigenetic marker of response to chemotherapy and prognosis in men with castration-resistant prostate cancer (CRPC). (2011) (3)
- DNA methylation is required to maintain DNA replication timing precision and 3D genome integrity (2020) (3)
- MicroRNA-196 a is regulated by ER and is a prognostic biomarker in ER + breast cancer (2019) (3)
- Chromatin Modifications in Cancer Cells Hypermethylation through a Sequential Change in Transcriptional Gene Silencing Promotes DNA (2004) (2)
- Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma (2014) (2)
- Loss of pl6INK4 Expression by Methylation Is Associated with Lifespan Extension of Human Mammary Epithelial Cells1 (2006) (2)
- MethPanel: a parallel pipeline and interactive analysis tool for multiplex bisulphite PCR sequencing to assess DNA methylation biomarker panels for disease detection (2020) (2)
- The H2A.Z-nucleosome code in mammals: emerging functions. (2022) (2)
- Early Insights into Cancer Epigenetics: Gene Promoter Hypermethylation Emerges as a Potential Biomarker for Cancer Detection. (2022) (1)
- Replication timing shapes the cancer epigenome and the nature of chromosomal rearrangements (2018) (1)
- S0118 A hierarchy of epigenetic changes in the developmental transition from brown to white perirenal adipose tissue (2016) (1)
- Transient exposure to miR-203 expands the differentiation capacity of pluripotent stem cells (2020) (1)
- Multiple links between 5-methylcytosine content of mRNA and translation (2020) (1)
- MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer (2019) (1)
- Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels (2020) (1)
- Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer (2020) (1)
- Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways (2014) (1)
- Target-Specific Profiling of RNA m5C Methylation Level Using Amplicon Sequencing. (2021) (1)
- Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas (2016) (1)
- Highsensitivity mapping ofmethylated cytosines (1994) (1)
- Circulating microRNAs associated with docetaxel-resistant castration resistant prostate cancer. (2014) (1)
- We are what we Eat: How Nutritional Compounds Such as Isoflavones Shape Our Epigenome (2011) (1)
- Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer (2019) (1)
- Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis (2012) (1)
- Role of 5-Hydroxymethylation and TET enzymes in remodelling the epigenome (2016) (1)
- BayMeth: improved DNA methylation quantification for affinity capture sequencing data using a flexible Bayesian approach (2014) (1)
- Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer (2020) (1)
- Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer (2017) (0)
- OP-HMGJ160147 3269..3283 (2016) (0)
- BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer (2021) (0)
- Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer (2021) (0)
- Companion Diagnostics and Biomarkers BCL-2 Hypermethylation Is a Potential Biomarker of Sensitivity to Antimitotic Chemotherapy in Endocrine-Resistant Breast Cancer (2013) (0)
- Methylome and transcriptome maps of human visceral and subcutaneous adipocytes reveal key epigenetic differences at developmental genes (2019) (0)
- Epigenetic Inheritance of Breast Cancer (2004) (0)
- Co-ordinate epigenetic silencing of a cluster of 3p22 genes flanking MLH1 in sporadic microsatellite unstable colorectal cancer. (2007) (0)
- DNA demethylation agents as a therapeutic approach in endocrine-resistant breast cancer (2019) (0)
- Multiplex bisulfite PCR resequencing of clinical FFPE DNA (2015) (0)
- Multiplex bisulfite PCR resequencing of clinical (2015) (0)
- Abstract A4: Whole genome sequencing of free circulating DNA from plasma of HGSOC patients (2013) (0)
- Epigenetic therapy targets the 3D epigenome in endocrine-resistant breast cancer (2023) (0)
- Additional file 2 — Supplementary figures and tables (2014) (0)
- Abstract 1997: Charting the DNA methylation landscape of prostate cancer associated fibroblasts (2017) (0)
- Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling (2016) (0)
- Target regions for Headloop PCR on gene (2011) (0)
- ZNF300P1 Encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer (2014) (0)
- 250 Modification of the histone code: effects of DNA methylation (2004) (0)
- Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression (2019) (0)
- Copy-number-aware differential analysis of (2012) (0)
- MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene (2015) (0)
- Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events (2012) (0)
- A novel microRNA-based strategy to expand the differentiation potency of stem cells (2019) (0)
- Procédé de diagnostic du cancer (2012) (0)
- Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten (2018) (0)
- GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol) (2022) (0)
- Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA (2017) (0)
- Post hoc analysis of a phase III study to test the association between circulating methylated glutathione s transferase (mGSTP1) DNA levels and response to docetaxel (DTX) in metastatic castration resistant prostate cancer (mCRPC). (2017) (0)
- Abstract 1980: Long-range regulation of HOTAIR identifies novel biomarkers of breast cancer outcome and suggests a role in genome instability (2016) (0)
- Epigenomics of mammary gland development (2018) (0)
- Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis (2015) (0)
- BRG1 promotes transcriptional patterns that are permissive to proliferation in cancer cells (2020) (0)
- Epigenetic changes during tumour development – Functional epigenetics study (2020) (0)
- Principle of Headloop suppression PCR (2011) (0)
- High‐resolution Epigenome Mapping Reveals Distinct and Divergent Roles for UHRF1 in the Maintenance of DNA Methylation (2020) (0)
- Oestrogen receptor α promotes prostate cancer progression through dual actions in both epithelia and stroma (2015) (0)
This paper list is powered by the following services:
Other Resources About Susan J. Clark
What Schools Are Affiliated With Susan J. Clark?
Susan J. Clark is affiliated with the following schools:
